Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bevantolol Hydrochloride
2. Ci 775
3. Ci-775
1. 59170-23-9
2. Bevantololum
3. Bevantololum [inn-latin]
4. 1-(3,4-dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol
5. 1-((2-(3,4-dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol
6. 1-((3,4-dimethoxyphenethyl)amino)-3-(m-tolyloxy)propan-2-ol
7. Nsc-132348
8. 1-[2-(3,4-dimethoxyphenyl)ethylamino]-3-(3-methylphenoxy)propan-2-ol
9. 34zxw6zv21
10. Chebi:238698
11. 1-(3,4-dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol
12. 1-[2-(3,4-dimethoxy-phenyl)-ethylamino]-3-m-tolyloxy-propan-2-ol
13. Bevantolol [inn:ban]
14. (+/-)-bevantolol; Dl-bevantolol; Nsc 132348
15. 1-[[2-(3,4-dimethoxyphenyl)ethyl]amino]-3-(3-methylphenoxy)-2-propanol
16. (+-)-bevantolol
17. Brn 2769444
18. Unii-34zxw6zv21
19. (+/-)-bevantolol
20. Bevantolol [mi]
21. Bevantolol [inn]
22. Bevantolol [who-dd]
23. Schembl49721
24. Mls003876814
25. Chembl314010
26. Dtxsid70860597
27. Hms3604b08
28. Hy-a0249
29. Nsc132348
30. 1-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-3-(3-methylphenoxy)propan-2-ol
31. 2-propanol, 1-((2-(3,4-dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-
32. Akos016014301
33. Db01295
34. Nsc 132348
35. Smr002529477
36. A917858
37. L013370
38. Q1956953
39. 1-[[2-(3,4-dimethoxyphenyl) Ethyl]amino]-3-(3-methyl-phenoxy)-2-propanol
40. (+/-)-1-((3,4-dimethoxyphenethyl)amino)-3-(m-tolyloxy)-2-propanol
41. 2-propanol, 1-((2-(3,4-dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-, (+/-)-
| Molecular Weight | 345.4 g/mol |
|---|---|
| Molecular Formula | C20H27NO4 |
| XLogP3 | 3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 10 |
| Exact Mass | 345.19400834 g/mol |
| Monoisotopic Mass | 345.19400834 g/mol |
| Topological Polar Surface Area | 60 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 355 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
For the treatment of angina pectoris and hypertension.
Bevantolol is a beta-1 adrenoceptor antagonist that has been shown to be as effective as other beta blockers for the treatment of angina pectoris and hypertension.
Adrenergic beta-1 Receptor Antagonists
Drugs that bind to and block the activation of ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Antagonists.)
C - Cardiovascular system
C07 - Beta blocking agents
C07A - Beta blocking agents
C07AB - Beta blocking agents, selective
C07AB06 - Bevantolol
Animal experiments confirm both agonist and antagonist effects on alpha-receptors, in addition to antagonist activity at beta-1 receptors. By binding and antagonizing beta-1 receptors Bevantolol inhibits the normal normal epinephrine-mediated sympathetic actions such as increased heart rate. This has the effect of decreasing preload and blood pressure.
ABOUT THIS PAGE
A Bevantolol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bevantolol, including repackagers and relabelers. The FDA regulates Bevantolol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bevantolol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bevantolol supplier is an individual or a company that provides Bevantolol active pharmaceutical ingredient (API) or Bevantolol finished formulations upon request. The Bevantolol suppliers may include Bevantolol API manufacturers, exporters, distributors and traders.
click here to find a list of Bevantolol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Bevantolol Drug Master File in Japan (Bevantolol JDMF) empowers Bevantolol API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Bevantolol JDMF during the approval evaluation for pharmaceutical products. At the time of Bevantolol JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Bevantolol suppliers with JDMF on PharmaCompass.
Bevantolol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bevantolol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bevantolol GMP manufacturer or Bevantolol GMP API supplier for your needs.
A Bevantolol CoA (Certificate of Analysis) is a formal document that attests to Bevantolol's compliance with Bevantolol specifications and serves as a tool for batch-level quality control.
Bevantolol CoA mostly includes findings from lab analyses of a specific batch. For each Bevantolol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bevantolol may be tested according to a variety of international standards, such as European Pharmacopoeia (Bevantolol EP), Bevantolol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bevantolol USP).
LOOKING FOR A SUPPLIER?
